news-details
Health,Watchlist

4 Healthcare & Biotech Stocks up over 25% past 10 days

⬆ 4 Healthcare & Biotech Stocks up over 25% past 10 days
Powered by HealthTechMovers.com


Below is a list of 4 Healthcare & Biotech Stocks up over 25% past 10 days and have been added to our watchlist.  These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.

One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals.  Click here for more on Tipranks.com.

Nuvectis Pharma, NVCT

Summary: Nuvectis Pharma Inc. is a biopharmaceutical company. It focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. Nuvectis Pharma Inc. is based in Fort Lee, NJ.
 
Ticker Company Sector Previous Close *Recent Price % Price Change Past 10 Days
NVCT Nuvectis Pharma Healthcare & Biotech $15.87 $$16.01 +67%
 

Click for Full Story >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Biomea Fusion, BMEA
Summary: Biomea Fusion Inc. is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion Inc. is based in REDWOOD CITY, Calif.
 
Ticker Company Sector Prev Close *Recent Price % Price Change Past 10 Days
BMEA Biomea Fusion Healthcare & Biotech $4.10 $4.45 +34%
 

Click for Full Story >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Compass Therapeutics, CMPX
Summary: Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.
 
Ticker Company Sector Prev Close *Recent Price % Price Change Past 10 Days
CMPX Compass Therapeutics Healthcare & Biotech $1.84 $2.10 +28%
 

Click for Full Story >>

Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------

Gracell Biotechnologies, GRCL
Summary: Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company. It involved in discovering and developing breakthrough cell therapies to address unmet medical needs in the treatment of cancer. Gracell Biotechnologies Inc. is based in SUZHOU, China.
 
Ticker Company Sector Prev Close *Recent Price % Price Change Past 10 Days
GRCL Gracell Biotechnologies Healthcare & Biotech $2.76 $3.02 +25%
 

Click for Full Story >>

Pricing & Percentages as of approximately 10:00am EST.